PLXDC2 Protein, Human (HEK293, His)
Based on 1 Customer Validation
PLXDC2 protein potentially contributes to tumor angiogenesis, influencing blood vessel formation in tumors. It interacts with CTTN, suggesting involvement in cellular activities related to cytoskeletal dynamics and cell migration. PLXDC2 Protein, Human (HEK293, His) is the recombinant human-derived PLXDC2 protein, expressed by HEK293 , with C-His labeled tag.
- Species: Human
- Source: HEK293
-
Storage:Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Biological Activity
PLXDC2 protein potentially contributes to tumor angiogenesis, influencing blood vessel formation in tumors. It interacts with CTTN, suggesting involvement in cellular activities related to cytoskeletal dynamics and cell migration. PLXDC2 Protein, Human (HEK293, His) is the recombinant human-derived PLXDC2 protein, expressed by HEK293 , with C-His labeled tag.
PLXDC2 protein may play a significant role in tumor angiogenesis, potentially influencing the process of blood vessel formation within tumor tissues. Additionally, it interacts with CTTN, suggesting a possible involvement in cellular activities associated with cytoskeletal dynamics and cell migration.
Technical Parameters
-
Species Human
-
Source HEK293
-
Tag C-8*His
-
Accession
Q6UX71-1 (K31-A454)
-
Molecular Construction
-
N-term
-
PLXDC2 (K31-A454)
Accession # Q6UX71-1 -
8*His
-
C-term
-
-
Protein Length
Extracellular Domain
-
Synonyms
PLXDC2; Plexin Domain-Containing Protein 2; Plexin Domain Containing 2; FLJ14623; TEM7R; Tumor Endothelial Marker 7-Related Precursor; PLXDC2-OT; 1200007L24Rik; Tumor Endothelial Marker 7-Related Protein
-
AA Sequence
KPGDQILDWQYGVTQAFPHTEEEVEVDSHAYSHRWKRNLDFLKAVDTNRASVGQDSPEPRSFTDLLLDDGQDNNTQIEEDTDHNYYISRIYGPSDSASRDLWVNIDQMEKDKVKIHGILSNTHRQAARVNLSFDFPFYGHFLREITVATGGFIYTGEVVHRMLTATQYIAPLMANFDPSVSRNSTVRYFDNGTALVVQWDHVHLQDNYNLGSFTFQATLLMDGRIIFGYKEIPVLVTQISSTNHPVKVGLSDAFVVVHRIQQIPNVRRRTIYEYHRVELQMSKITNISAVEMTPLPTCLQFNRCGPCVSSQIGFNCSWCSKLQRCSSGFDRHRQDWVDSGCPEESKEKMCENTEPVETSSRTTTTVGATTTQFRVLTTTRRAVTSQFPTSLPTEDDTKIALHLKDNGASTDDSAAEKKGGTLHA
-
Predicted Molecular Mass
49.1 kDa
-
Molecular Weight
Approximately 75-95 kDa, based on SDS-PAGE under reducing conditions, due to the glycosylation.
-
Glycosylation
Yes
-
Purity
≥ 95%, as determined by reducing SDS-PAGE.
Product Properties
Lyophilized powder
Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4, 8% trehalose.
<0.05 EU/μg, determined by LAL method.
It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O.
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Room temperature in continental US; may vary elsewhere.
Documentation
-
Data Sheet (237 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)